The incidence of congestive heart failure associated with antidiabetic therapies

Increased risk for CHF in persons with type 2 diabetes is well established. Our objectives were to estimate the CHF risk associated with specific therapies for diabetes and to determine the differences in incidence rates of CHF associated with adding various antidiabetic agents.

[1]  M. Stern,et al.  The insulin resistance syndrome: the controversy is dead, long live the controversy! , 1994, Diabetologia.

[2]  A. Fontbonne.  Why can high insulin levels indicate a risk for coronary heart disease? , 1994, Diabetologia.

[3]  G. Reaven,et al.  Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease , 1994, Diabetologia.

[4]  R. Jarrett.  Why is insulin not a risk factor for coronary heart disease? , 1994, Diabetologia.

[5]  H. Keen,et al.  The Bedford Survey: Ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics , 1982, Diabetologia.

[6]  J. Murabito,et al.  Lifetime Risk for Developing Congestive Heart Failure: The Framingham Heart Study , 2002, Circulation.

[7]  S. Inzucchi.  Oral antihyperglycemic therapy for type 2 diabetes: scientific review. , 2002, JAMA.

[8]  G. Nichols,et al.  Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors. , 2001, Diabetes care.

[9]  Jennifer Y. Liu,et al.  Glycemic Control and Heart Failure Among Adult Patients With Diabetes , 2001, Circulation.

[10]  F. Nuttall,et al.  Two years of intensive glycemic control and left ventricular function in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM). , 2000, Diabetes care.

[11]  A. Folsom,et al.  Nontraditional Risk Factors for Coronary Heart Disease Incidence among Persons with Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study , 2000, Annals of Internal Medicine.

[12]  K. Eagle,et al.  The treatment of elderly diabetic patients with acute myocardial infarction: insight from Michigan's Cooperative Cardiovascular Project. , 2000, Archives of internal medicine.

[13]  J. Gardin,et al.  Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. , 2000, Journal of the American College of Cardiology.

[14]  H. Gerstein,et al.  Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview , 2000, The Lancet.

[15]  W. Kannel,et al.  Vital epidemiologic clues in heart failure. , 2000, Journal of clinical epidemiology.

[16]  M. Laakso,et al.  Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with Type II diabetes , 2000, Diabetologia.

[17]  M. Alam,et al.  Clinical predictors of heart failure in patients with first acute myocardial infarction. , 1999, American heart journal.

[18]  W. Aronow,et al.  Comparison of incidences of congestive heart failure in older African-Americans, Hispanics, and whites. , 1999, The American journal of cardiology.

[19]  G. Nichols,et al.  Type 2 diabetes: incremental medical care costs during the first 8 years after diagnosis. , 1999, Diabetes care.

[20]  Christianna S. Williams,et al.  Risk factors for heart failure in the elderly: a prospective community-based study. , 1999, The American journal of medicine.

[21]  G. Nichols,et al.  Ten-year follow-up of antidiabetic drug use, nonadherence, and mortality in a defined population with type 2 diabetes mellitus. , 1999, Clinical therapeutics.

[22]  W. Aronow,et al.  Incidence of heart failure in 2,737 older persons with and without diabetes mellitus. , 1999, Chest.

[23]  R. D'Agostino.  Adjustment Methods: Propensity Score Methods for Bias Reduction in the Comparison of a Treatment to a Non‐Randomized Control Group , 2005 .

[24]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[25]  R. Holman,et al.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) , 1998, The Lancet.

[26]  E. Braunwald.  Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. , 1997, The New England journal of medicine.

[27]  M. Hanefeld,et al.  Predictors of coronary heart disease and death in NIDDM: The Diabetes Intervention Study experience , 1997, Diabetologia.

[28]  K. Malmberg.  Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus , 1997, BMJ.

[29]  F. Nuttall,et al.  Cardiovascular Events and Correlates in the Veterans Affairs Diabetes Feasibility Trial Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes , 1997 .

[30]  M. Stern.  Do Non-Insulin-dependent Diabetes Mellitus and Cardiovascular Disease Share Common Antecedents? , 1996, Annals of Internal Medicine.

[31]  Gary G. Koch,et al.  Categorical Data Analysis Using The SAS1 System , 1995 .

[32]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[33]  M. Laakso,et al.  High fasting plasma insulin is an indicator of coronary heart disease in non-insulin-dependent diabetic patients and nondiabetic subjects. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[34]  A. Fontbonne,et al.  Diabetes, hyperglycaemia, hyperinsulinaemia and atherosclerosis: epidemiological data. , 1987, Diabete & metabolisme.

[35]  W. M. Smith.  Epidemiology of congestive heart failure. , 1985, The American journal of cardiology.

[36]  E. Standl,et al.  High serum insulin concentrations in relation to other cardiovascular risk factors in macrovascular disease of type 2 diabetes. , 1985, Hormone and metabolic research. Supplement series.

[37]  J. Mann,et al.  Hyperinsulinaemia is associated with development of electrocardiographic abnormalities in diabetics. , 1984, Diabetes research.

[38]  D. Rubin,et al.  The central role of the propensity score in observational studies for causal effects , 1983 .

[39]  G. Knatterud,et al.  Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VII. Mortality and selected nonfatal events with insulin treatment. , 1978, JAMA.

[40]  W. Kannel,et al.  Role of diabetes in congestive heart failure: the Framingham study. , 1974, The American journal of cardiology.

[41]  R. Santen,et al.  Atherosclerosis in diabetes mellitus. Correlations with serum lipid levels, adiposity, and serum insulin level. , 1972, Archives of internal medicine.

[42]  G. Knatterud,et al.  Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. 3. Clinical implications of UGDP results. , 1971, JAMA.